Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients

Bibliography

• Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens 2003;12:330-5
   Google Scholar
• Sica DA. Pharmacotherapy review: calcium channel blockers. J Clin Hypertens 2006;8:53-6
   Google Scholar
• Chrisant SG. Proactive compared with passive adverse event recognition: calcium channel blocker-associated edema. J Clin Hypertens 2008;10:716-22
   Web of Science ®Google Scholar
• Gustaffson D. Microvascular mechanisms involved in calcium antagonist edema formation. J Cardiovasc Pharmacol 1987;10(Suppl 1):S121-31
   Google Scholar
• Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Am J Hypertens 2001;14:978-9
   PubMed Web of Science ®Google Scholar
• Gustaffsson D, Grande PE, Borgstrom P, Lindberg L. Effects of calcium antagonists on myogenic and neurogenic control of resistance and capacitance vessels in cat skeletal muscle. J Cardiovasc Pharmacol 1988;12:413-22
   PubMed Web of Science ®Google Scholar
• Salmasi AM, Belcaro G, Nicolaides AN. Impaired venoarteriolar reflex as a possible cause for nifedipine-induced ankle edema. Int J Cardiol 1991;30:303-7
   PubMed Web of Science ®Google Scholar
• Fogari R, Malamani GD, Zoppi A, Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind, randomized, parallel group study. Curr Ther Res Clin Exp 2000;61:850-62
   Web of Science ®Google Scholar
• Fogari R, Mugellini A, Zoppi A, Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens 2003;16:596-9
   PubMed Web of Science ®Google Scholar
• Fogari R. Ankle edema and sympathetic activation. Drugs 2005;65(Suppl 2):21-7
   PubMedGoogle Scholar
• Weir M, Rosenberg C, Fink JC. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE-inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens 2001;14:963-8
   PubMed Web of Science ®Google Scholar
• Guazzi MD, De Cesare N, Galli C, Calcium channel blockade with nifedipine and angiotensin converting enzyme with captopril in the therapy of patients with severe primary hypertension. Circulation 1984;70:279-84
   PubMed Web of Science ®Google Scholar
• Messerli FH, Oparil S, Feng Z. Comparison of the efficacy and side-effects of combination therapy of angiotensin converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol 2000;86:1182-7
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Dell'Olmo G, Melillo E, Mariani M. Amlodipine, enalapril and dependent leg edema in essential hypertension. Hypertension 2000;35:621-5
   PubMed Web of Science ®Google Scholar
• Fogari R, Malamani GD, Zoppi A, Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2003;17:207-12
   PubMed Web of Science ®Google Scholar
• Fogari R, Malamani GD, Zoppi A, Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way cross-over study. Clin Ther 2007;29:413-18
   PubMed Web of Science ®Google Scholar
• Philipp T, Smith TR, Glazer R, Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther 2007;29:563-80
   PubMed Web of Science ®Google Scholar
• Fogari R, Zoppi A, Derosa G, Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens 2007;21:220-4
   PubMed Web of Science ®Google Scholar
• De la Sierra A. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens 2009;23:503-11
   PubMed Web of Science ®Google Scholar
• Fogari R, Malamani GD, Corradi L, Effect of valsartan or olmesartan addition to amlodipine on ankle oedema in hypertensive patients. Adv Ther 2010;27:48-55
   PubMed Web of Science ®Google Scholar
• Tabizchi R, King KA, Pang CC. Direct and indirect effects of angiotensin II on venous tone in conscious rats. Eur J Pharmacol 1992;219:141-5
   PubMed Web of Science ®Google Scholar
• Fernandes L, Loiola RA, Tostes RCA, Angiotensin II-induced venoconstriction involves both AT1 and AT2 receptors and is counterbalanced by nitric oxide. Peptides 2005;26:2458-63
   PubMedGoogle Scholar
• Rea RF, Eckberg DL, Fritsch JM, Goldstein DS. Relation of plasma norepinephrine and sympathetic traffic during hypertension in humans. Am J Physiol 1990;258:R982-6
   Google Scholar
• Abdelrahman AM, Burrel LM, Johnston CI. Blockade of the renin-angiotensin system at different sites: effect of renin, angiotensin and aldosterone. J Hypertens 1993;11(Suppl 3):S49-52
   PubMedGoogle Scholar
• Hansson L, Hedner T, Dahlof B. Prospective, Randomized, Open, Blinded End point (PROBE) study: a novel design for intervention trials. Blood Press 1992;1:113-14
   PubMedGoogle Scholar
• Lauderer A. Die Gewebspannung in ihren Einfluss anf die Ortliche Blut-vud Lymphbewegung. Fogel FCW; Leipzig: 1884. p. 174
   Google Scholar
• Burch GE, Sodeman WA. The estimation of subcutaneous pressure by direct method. J Clin Invest 1937;16:845-50
   PubMedGoogle Scholar
• Malamani V. Modificazioni della pressione dei tessuti nell'edema provocato. Boll Soc Ital Biol Sper 1947;23:125-31
   Google Scholar
• Malamani V. La pressione nei tessuti. Tipografia Popolare; Pavia: 1957. p. 485
   Google Scholar
• Remie R, Zaagsma J. A new tecnique for the study of vascular presynaptic receptors in freely moving rats. Heart Circ Physiol 1986;251:4463-7
   Google Scholar
• Hjemdahl P. Plasma catecholamines as markers for sympathoadrenal activity in human primary hypertension. Pharmacol Toxicol 1988;63(Suppl 1):S27-31
   PubMedGoogle Scholar
• Nussberger J, Fasanella d'Amore T, Porchet M, Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol 1987;9:39-44
   PubMed Web of Science ®Google Scholar
• Fogari R, Preti P, Zoppi A, Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. Am J Hypertens 2005;18:577-83
   PubMed Web of Science ®Google Scholar
• Dendorfer A, Raasch W, Tempel K, Dominiak P. Interaction between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol 1998;93:24-9
   PubMedGoogle Scholar
• Balt JC, Mathy MJ, Pfaffendorf M, Van Zwieten PA. Sympathoinhibitory properties of various AT1 receptor antagonists. J Hypertens 2002;20(Suppl 5):S3-11
   PubMedGoogle Scholar
• Ye S, Zhong H, Duong N, Campese VM. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 2002;39:1101-6
   PubMed Web of Science ®Google Scholar